John Moroney to Receptor, ErbB-2
This is a "connection" page, showing publications John Moroney has written about Receptor, ErbB-2.
Connection Strength
0.022
-
Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer. J Clin Oncol. 2011 Jul 01; 29(19):e572-5.
Score: 0.022